Urology

Five-Year, $6.9 Million Study Looks At Impact Of Urologic Disease On Americans

Published in Medical Letter on the CDC and FDA, September 9th, 2001

A University of California, Los Angeles, researcher is launching a first-of-its-kind study to document the impact of urologic diseases on the American public, an endeavor that may influence insurance coverage, access to care, the allocation of research dollars, and the availability of treatments and services.

Study leader Dr. Mark S. Litwin, a researcher at UCLA's Jonsson Cancer Center and an associate professor in the departments of Urology and Health Services, said the effort represents the first coordinated attempt to detail the significant burden of a variety of urologic diseases that strike American men, women, and children.

"The burden of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2001-09-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry